Industry wants to avoid surprises in remote regulatory assessments
Regulatory NewsMary Ellen Schneider
Audit/inspectionBiologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsUnited StatesRegulatory NewsMary Ellen SchneiderAudit/inspectionBiologics/ biosimilars/ vaccinesMedical DevicesPharmaceuticalsUnited States